NCT01720459

Effects of Micronized Trans-resveratrol Treatment on Polycystic Ovary Syndrome (PCOS) Patients

Effects of Micronized Trans-resveratrol Treatment on Clinical, Endocrine, Metabolic and Biochemical Parameters of Women With Polycystic Ovary Syndrome: Placebo-controlled Randomized Single-blind Study

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: Poznan University of Medical Sciences · Academic / Other
• Sex: Female
• Age: 18 Years – 40 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine whether micronized trans-resveratrol improves clinical (excessive hair, menstrual cycle), endocrine (androgens)and metabolic (lipids, markers of systemic inflammation) in women with polycystic ovary syndrome (PCOS).

Conditions

• Polycystic Ovary Syndrome (PCOS)

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Micronized trans-resveratrol
DIETARY_SUPPLEMENT	Placebo

Timeline

• Start date: 2012-12-01
• Primary completion: 2013-12-01
• Completion: 2014-12-01
• First posted: 2012-11-02
• Last updated: 2012-11-02

Locations

1 site across 1 country: Poland